Bristol Myers Squibb (BMY)
(Real Time Quote from BATS)
$45.02 USD
+0.32 (0.72%)
Updated Apr 26, 2024 03:42 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.68 |
# of Recs in ABR | 23 |
Average Target Price | $56.50 |
LT Growth Rate | 5.00% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 75 of 252 |
Current Quarter EPS Est: | 1.75 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 5 |
Buy | 1 | 1 | 0 | 0 | 0 |
Hold | 17 | 18 | 18 | 17 | 16 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.67 | 2.68 | 2.71 | 2.70 | 2.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/22/2024 | Cantor Fitzgerald & Co | Olivia Brayer | Hold | Hold |
4/15/2024 | Truist Securities | Robyn Karnauskas | Strong Buy | Strong Buy |
4/9/2024 | Not Identified | Not Identified | Hold | Hold |
4/1/2024 | William Blair | Matt Phipps | Hold | Hold |
3/27/2024 | Guggenheim Securities | Seamus Fernandez | Hold | Hold |
2/6/2024 | Daiwa America | Narumi Nakagiri | Moderate Buy | Moderate Buy |
11/1/2023 | Berenberg Bank | Luisa Hector | Hold | Hold |
10/27/2023 | BMO Capital Markets | Evan Seigerman | Strong Buy | Hold |
10/26/2023 | SVB Securities | David Risinger | Hold | Hold |
9/6/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.